X-ray dose and associated risks from radiofrequency catheter ablation procedures
S L McFadden, BSc, MSc
1
R B Mooney, BSc
2 and
P H Shepherd, MSc, DCR-T
3
1 Angiocardiographic Suite, Royal Victoria Hospital, Grosvenor Road, Belfast, BT12 6BA, 2 Northern Ireland Medical Physics Agency, Forster Green Hospital, 110 Saintfield Road, Belfast BT8 4HD and 3 University of Ulster at Jordanstown, Shore Road, Newtownabbey, County Antrim, BT37 OQB, UK

View larger version (18K):
[in a new window]
|
Figure 1. Skin dose as a function of dosearea product (DAP) for radiofrequency ablation procedures, n=50, r=0.71, p<0.01. The solid regression line was forced through the origin. (--), maximum rate of increase of skin dose with DAP; (---) threshold skin doses for transient and main erythema.
|
|

View larger version (16K):
[in a new window]
|
Figure 2. Skin dose as a functionof fluoroscopy time for radiofrequency ablation procedures, n=50, correlation coefficient (r)=0.64, p<0.01.The regression line was forced through the origin. (---), threshold skindoses for transient and main erythema.
|
|
Copyright © 2002 by the British Institute of Radiology.